Product Information
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.1825 per GM under NDC 45802081696. Its NADAC has been published 343 times since Mar 11, 2020.
FDA first approved this application on Dec 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT
Calcipotriene, Betamethasone DipropionateStrength
.643; 50 mg/g; ug/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802081696
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA200174FDA Approved
12/12/2014
TE Code
AB
On Market Since
1/30/2020
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has been published 343 times since Mar 11, 2020, and over the history we have for it it has declined 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1825 per GM |
|---|---|
| All-time high | $10.0482 (Apr 15, 2020) |
| All-time low | $2.0221 (Nov 20, 2024) |
| 52-week high | $2.8401 |
| 52-week low | $2.1825 |
| Median price | $3.4671 |
| Average price | $4.3107 |
| Largest weekly change | +49.2% (Jan 20, 2021) |
| Weeks tracked | 343 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcipotriene, Betamethasone Dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.1825 per GM (NDC 45802081696), effective Sep 30, 2026.
How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has declined 78.3%. It has been tracked across 343 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
Since Mar 11, 2020, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT has ranged from a low of $2.0221 (Nov 20, 2024) to a high of $10.0482 (Apr 15, 2020), with a median of $3.4671 per GM.
Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT, is $1.4331 per GM — about 34% below CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT.
Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT?
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% OINTMENT (NDC 45802081696) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.